Paul Rubinstein

22 posts

Paul Rubinstein

Paul Rubinstein

@PaulRubinstein4

Malignant heme #lymphoma doc #taking care of persons living with HIV and Cancer

Chicago, IL Katılım Aralık 2019
260 Takip Edilen81 Takipçiler
Paul Rubinstein retweetledi
amfAR
amfAR@amfAR·
Breaking news from #CROI2025: Two probable HIV cures, the Chicago and Oslo Patients, were announced. If confirmed, the total number of known cures will rise to 10. Read article: amfar.org/news/researche…
English
1
5
17
9.2K
Paul Rubinstein retweetledi
University of Illinois Cancer Center
At #CROI2025, our physician researcher @PaulRubinstein4 of @thisisuic @UIHealth presented findings from Chicago Patient (8th person living w/ HIV in remission off #ART after CCR5d32/d32 allogeneic stem cell transplant). @NIAIDNews,#NIAIDVRC,@theNCI & @CookCtyHealth collab vital.
POZ Magazine@pozmagazine

If the men remain in remission, they will be the ninth and tenth known cases of a functional cure after the procedure. #HIV #HIVCure poz.com/article/two-pe…

English
0
5
3
1.2K
Paul Rubinstein retweetledi
UIC Heme Onc Fellowship
UIC Heme Onc Fellowship@UIC_HO_Fellows·
Poster presentation at @asco #GU25 by our fellow Dr. Michael Weinfeld looking at low-dose abiraterone adherence/cost vs standard dose abiraterone 💊
UIC Heme Onc Fellowship tweet media
English
0
4
13
1.2K
Paul Rubinstein retweetledi
UIC Heme Onc Fellowship
UIC Heme Onc Fellowship@UIC_HO_Fellows·
Congrats to our all ⭐️ graduating fellows!! Dr. Kevin Prescott Dr. Ana Maria Avila Dr. Lucas Maahs We are so excited for what the future holds for you all! @UICancerCenter
UIC Heme Onc Fellowship tweet mediaUIC Heme Onc Fellowship tweet media
Chicago, IL 🇺🇸 English
1
7
39
2.9K
Paul Rubinstein retweetledi
Lymphoma Hub
Lymphoma Hub@lymphomahub·
CONGRESS | #ASH23 | Franck Morschhauser, University of Lille, presents a post-hoc analysis of the POLARIX study on the prevalence & clinical outcomes of molecularly defined subtypes of DLBCL. N=594, high-risk DHL/THL patients with DZsigPos DLBCL may benefit from Pola-R-CHP vs R-CHOP. According to LymphGen classification, EZB, MCD, and unidentified subtypes may benefit from Pola-R-CHP. #lymphoma #lymsm #leusm
Lymphoma Hub tweet mediaLymphoma Hub tweet mediaLymphoma Hub tweet mediaLymphoma Hub tweet media
English
1
11
29
5.6K
Sheeba Ba Aqeel, MD
Sheeba Ba Aqeel, MD@sheeba_baaqeel·
Oncology certification ✅ Blessed and thankful to be training at @RoswellHemOnc @RoswellPark and learning from the best attendings and mentors without whom this wouldn’t be possible
Sheeba Ba Aqeel, MD tweet media
English
13
0
45
4K
Paul Rubinstein retweetledi
Graham Collins
Graham Collins@graham74GC·
Rutherford et al - BV-AVD v N-AVD in older Hodgkin - SWOG 1836 study, 60y+, n=103 (approx 50 each arm) - med age 66, more high risk in N-AVD - Less tox with N-AVD: GI, PN, sepsis - 1y PFS 64v93% - 1y OS 83v95% (not stat signif) - NRM 4v14% A game changer. #ASH23 #lymsm
Graham Collins tweet mediaGraham Collins tweet mediaGraham Collins tweet mediaGraham Collins tweet media
English
0
28
90
11.3K
Paul Rubinstein retweetledi
Irum Khan
Irum Khan@Irumkhan_hem·
A prospective approach linking individual level pt reported SDOH data to early adverse AML outcomes. Proud of @EshanaShahMD for an excellent oral abstract and the dedicated efforts of leukemia teams, trainees and patients @UICancerCenter and @LurieCancer
Irum Khan tweet media
English
2
8
28
4.1K
Paul Rubinstein retweetledi
Karen Sweiss
Karen Sweiss@KarenSweiss·
Art of Oncology Special Edition ... honoring the personal stories that have touched our ❤️ and made us cry. I still go back to many of these and read them. We should take pauses in our busy lives and reflect on how humbling it is to treat cancer ascopubs.org/jco/art-of-onc…
English
1
2
19
2.1K
Paul Rubinstein retweetledi
Maarten van Smeden
Maarten van Smeden@MaartenvSmeden·
It is the only way
Maarten van Smeden tweet media
English
81
2K
11.8K
2M
Paul Rubinstein retweetledi
Karine Tawagi MD
Karine Tawagi MD@DrKarineTawagi·
Out today in collaboration with @asco, Dr. Reizine & I discuss why exercise is important for patients with prostate cancer, common challenges & types of exercises that may be helpful! 🏃‍♂️🚴🏽 🧘‍♂️ 🏋🏽‍♀️ #prostatecancer #guonc cancer.net/blog/2023-08/w…
Karine Tawagi MD tweet media
English
1
9
52
4.9K
Paul Rubinstein retweetledi
Kate Lurain
Kate Lurain@DrKateLurain·
Excited to see the important results of BV-AVD in HIV+ Hodgkin lymphoma in print! 2-yr PFS 87% and OS 92% plus increases CD4/CD8 counts. Great work by Paul Rubinstein and @AMC_Studies sciencedirect.com/science/articl…
English
0
5
24
2.1K